Parkman Healthcare Partners LLC Reduces Position in Oscar Health, Inc. (NYSE:OSCR)

Parkman Healthcare Partners LLC decreased its holdings in shares of Oscar Health, Inc. (NYSE:OSCR - Free Report) by 50.0% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 125,000 shares of the company's stock after selling 125,000 shares during the quarter. Parkman Healthcare Partners LLC owned about 0.05% of Oscar Health worth $1,680,000 as of its most recent SEC filing.

A number of other large investors have also modified their holdings of the business. Jacobs Levy Equity Management Inc. boosted its position in shares of Oscar Health by 37.8% during the 4th quarter. Jacobs Levy Equity Management Inc. now owns 1,741,306 shares of the company's stock valued at $23,403,000 after acquiring an additional 477,634 shares during the last quarter. Lingotto Investment Management LLP acquired a new position in shares of Oscar Health during the 4th quarter valued at about $2,543,000. GDS Wealth Management boosted its position in shares of Oscar Health by 1,545.3% during the 4th quarter. GDS Wealth Management now owns 345,817 shares of the company's stock valued at $4,648,000 after acquiring an additional 324,798 shares during the last quarter. Victory Capital Management Inc. boosted its position in shares of Oscar Health by 296.0% during the 4th quarter. Victory Capital Management Inc. now owns 231,059 shares of the company's stock valued at $3,105,000 after acquiring an additional 172,706 shares during the last quarter. Finally, Connor Clark & Lunn Investment Management Ltd. acquired a new position in shares of Oscar Health during the 4th quarter valued at about $5,672,000. Hedge funds and other institutional investors own 75.70% of the company's stock.

Oscar Health Trading Up 0.5%

NYSE OSCR opened at $16.90 on Wednesday. The firm's 50-day moving average is $13.37 and its two-hundred day moving average is $14.63. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The stock has a market capitalization of $4.23 billion, a P/E ratio of -844.58 and a beta of 1.75.

Oscar Health (NYSE:OSCR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. The company had revenue of $3 billion for the quarter, compared to analysts' expectations of $2.87 billion. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. Oscar Health's revenue for the quarter was up 42.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.62 earnings per share. On average, sell-side analysts anticipate that Oscar Health, Inc. will post 0.69 earnings per share for the current year.

Analyst Upgrades and Downgrades

Separately, Wells Fargo & Company cut shares of Oscar Health from an "overweight" rating to an "equal weight" rating and lowered their price target for the company from $20.00 to $16.00 in a research report on Thursday, March 13th. Two investment analysts have rated the stock with a sell rating, two have issued a hold rating, two have issued a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Oscar Health has a consensus rating of "Hold" and a consensus price target of $20.08.

Oscar Health Company Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.